News and Articles

InCube in the News

Read more about InCube, Mir and our portfolio companies in the news. InCube portfolio company, Rani Therapeutics, is garnering attention for its novel approach to the oral delivery of biologics, considered the Holy Grail in Drug Delivery.

Recent Articles

Current Year Media

Oral Injections Tested in Proof-of-Concept Trial

03/10/2020
Current Year Media

Converting injectable drugs into pills

03/10/2020
Current Year Media

Pill with tiny needle for painless injections passes first human trial

01/30/2020
Current Year Media

Rani Therapeutics eyes potential IPO as robotic pill technology takes shape

01/30/2020
Current Year Press

Rani Therapeutics Announces Positive Phase I Study Results of Oral Octreotide using RaniPill™

01/30/2020
Current Year Media

A Conversation with Mir Imran on The Future of Healthcare

11/14/2019
Current Year Media

How This 20-Time Founder With Hundreds of Patents Got His Start

10/09/2019
Media

Episode 24: The Story of Mir Imran, Medical Devices and Big Exits

09/10/2019
Media

Inventor Mir Imran: “I’d like to see the art of innovation taught in K-12"

09/10/2019
Press

Shire bags option on device-enabled oral FVIII drug

12/05/2018
Press

Robotic-Pill Maker Rani Therapeutics Backed by Shire

12/05/2018
Press

Market Intel: Robotic Pills And The Future Of Painless Drug Delivery

09/13/2018
Press

PharmaVoice on Biologics (including commentary from Mir Imran)

09/07/2018
Press

Rani Therapeutics' CEO Mir Imran Selected For The 2018 Upstart 50 List

09/07/2018
Press

Swallowing A Biologic Drug?

08/27/2018
Press

Why biosimilars won’t be the only shake up in biologics

08/08/2018
Press

Mir Imran named to PharmaVOICE 100

08/06/2018
Press

The billion-dollar startups revolutionizing healthcare in 2018

07/17/2018